| 摘要 |
Disclosed is a use of a peptide comprising the amino acid sequence of any one of SEQ ID NOs: 109, 146, 153, 192, and 193 in the manufacture of a medicament for reducing weight gain, treating hyperglycemia, reducing blood glucose levels, or normalising blood glucose levels in an adult human wherein the use is characterised by a weekly dosage of 1 mg to 40 mg per week. The sequences are as defined in the specification. |
